Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo Study

Diabetes Care

Volumn 25, Issue 1, 2002, Pages 55-60

  Oh, Jee Young ^a   Barrett Connor, Elizabeth ^a   Wedick, Nicole M ^a   Wingard, Deborah L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; SEX HORMONE; TESTOSTERONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOME; DIABETOGENESIS; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; TESTOSTERONE BLOOD LEVEL; AGING; BLOOD; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS; DRINKING BEHAVIOR; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOKING; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; ALCOHOL DRINKING; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CALIFORNIA; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; GONADAL STEROID HORMONES; HUMANS; INSULIN; MALE; MIDDLE AGED; SMOKING; TRIGLYCERIDES;

EID: 0036357643     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.1.55     Document Type: Article

References (44)

1. Seidell JC, Björmorp P, Sjöström L, Kvist H, Sannerstedt R: Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39:897-901, 1990
2. Haffner SM, Valdez RA, Mykkänen L, Stern MP, Katz MS: Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 43: 599-603, 1994
3. Haffner SM: Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord 24 (Suppl.):S56-S58, 2000
4. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH: Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57:304-310, 1983
5. Haffner SM, Katz MS, Stern MP, Dunn JF: The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 37:683-688, 1988
6. Haffner SM, Dunn JF, Katz MS: Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose and insulin concentrations in postmenopausal women. Metabolism 41:278-284, 1992
7. Haffner SM, Katz MS, Dunn JF: Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes Relat Metab Disord 15:471-478, 1991
8. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD: Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20:151-156, 1991
9. Soler JT, Folsom AR, Kaye SA, Prineas RJ: Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis 79:21-27, 1989
10. Holmäng A, Svedberg J, Jennische E, Björntorp P: Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J Physiol 259:E555-E560, 1990
11. Holmäng A, Björntorp P: The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 146:505-510, 1992
12. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
13. Anderson DC: Sex-hormone-binding globulin. Clin Endocrinol 3:69-96, 1974
14. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men: MRFIT Research Group Multiple Risk Factor Intervention Trial. Am J Epidemiol 143:889-897, 1996
15. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23:490-494, 2000
16. Tibblin G, Adlerberth A, Lindstedt G, Bjôrntorp P: The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 45:1605-1609, 1996
17. Andersson B, Marin P, Lissner L, Vermeulen A, Bjömtorp P: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405-411, 1994
18. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stem MP: Decreased sex hormone-binding globulin predicts non-insulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 77:56-60, 1993
19. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Björntorp P: Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM: 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 40:123-128, 1991
20. Goodman-Gruen D, Barrett-Connor E: Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23:912-918, 2000
21. Wingard DL, Sinsheimer P, Barrett-Connor E, McPhillips JB: Community-based study of prevalence of NIDDM in older adults. Diabetes Care 13 (Suppl. 2):S3-S8, 1990
22. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738, 1971
23. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
24. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
26. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
27. Tremblay RR, Dube JY: Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605, 1974
28. Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metdb 50:113-116, 1980
29. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174, 1989
30. Holmäng A, Larsson BM, Brzezinska Z, Björntorp P: Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats. Am J Physiol 262: E851-E855, 1992
31. Morley JE: Androgens and aging. Maturitas 38:61-73, 2001
32. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D: Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:645-651, 2000
33. Phillips GB, Tuck CH, Jing TY, Boden-Albala B, Lin IF, Dahodwala N, Sacco RL: Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care 23:74-79, 2000
34. Grodin JM, Siiteri PK, MacDonald PC: Source of estrogen production in post-menopausal women. J Clin Endocrinol Metab 36:207-214, 1973
35. Longcope C, Tait JF: Validity of metabolic clearance and interconversion rates of estrone and 17-beta-estradiol in normal adults. J Clin Endocrinol Metab 32:481-490, 1971
36. Longcope C, Kato T, Horton R: Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest 48:2191-2201, 1969
37. Tchernof A, Després JP, Dupont A, Bélanger A, Nadeau A, Prud'homme D, Moorjani S, Lupien PJ, Labrie F: Relation of steroid hormones to glucose tolerance and plasma insulin levels in men: importance of visceral adipose tissue. Diabetes Care 18:292-299, 1995
38. Haffner SM, Karhapää P, Mykkänen L, Laakso M: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43:212-219, 1994
39. Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM: Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status: Virgilio-Menopause-Health Group. Metabolism 46:5-9, 1997
40. Laughlin GA, Barrett-Connor E: Gender differences in the influence of aging on androgen and estrogen levels: the Rancho Bernardo Study. In Proceedings of the 82nd Annual Endocrine Society Meeting, Toronto, Canada. Endocrine Society, 2000, p. 393
41. American Diabetes Association: Screening for diabetes. Diabetes Care 24 (Suppl. 1):S21-S24, 2001
42. Reaven PD, Barrett-Connor EL, Browner DK: Abnormal glucose tolerance and hypertension. Diabetes Care 13:119-125, 1990
43. Cauley JA, Gutai JP, Kuller LH, Powell JG: Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 133:50-57, 1991
44. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG: The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120-1131, 1989